Show simple item record

dc.contributor.authorBrinkman, DJ
dc.contributor.authorTichelaar, J
dc.contributor.authorMokkink, LB
dc.contributor.authorChristiaens, T
dc.contributor.authorLikic, R
dc.contributor.authorMaciulaitis, R
dc.contributor.authorCosta, J
dc.contributor.authorSanz, EJ
dc.contributor.authorMaxwell, SR
dc.contributor.authorRichir, MC
dc.contributor.authorvan Agtmael, MA
dc.contributor.authorEducation Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and its affiliated Network of Teachers in Pharmacotherapy (NOTIP)
dc.date.accessioned2021-07-30T17:17:43Z
dc.date.available2017-11-25
dc.date.available2021-07-30T17:17:43Z
dc.date.issued2018-11-05
dc.identifier.citationBrinkman, D.J., Tichelaar, J., Mokkink, L.B., Christiaens, T., Likic, R., Maciulaitis, R., Costa, J., Sanz, E.J., Maxwell, S.R., Richir, M.C., van Agtmael, M.A. and (2018), Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study. Clin. Pharmacol. Ther., 104: 317-325. https://doi.org/10.1002/cpt.962en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/73341
dc.description.abstractHarmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to ensure that the prescribing competency of future doctors is of a uniform high standard. As there are currently no uniform requirements, our aim was to achieve consensus on key learning outcomes for undergraduate CPT education in Europe. We used a modified Delphi method consisting of three questionnaire rounds and a panel meeting. A total of 129 experts from 27 European countries were asked to rate 307 learning outcomes. In all, 92 experts (71%) completed all three questionnaire rounds, and 33 experts (26%) attended the meeting. 232 learning outcomes from the original list, 15 newly suggested and 5 rephrased outcomes were included. These 252 learning outcomes should be included in undergraduate CPT curricula to ensure that European graduates are able to prescribe safely and effectively. We provide a blueprint of a European core curriculum describing when and how the learning outcomes might be acquired.en_US
dc.format.extent317 - 325
dc.languageeng
dc.language.isoenen_US
dc.publisherWiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeuticsen_US
dc.relation.ispartofClinical Pharmacology & Therapeutics
dc.rightsCreative Commons Attribution-NonCommercial License
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectConsensusen_US
dc.subjectCurriculumen_US
dc.subjectDelphi Techniqueen_US
dc.subjectDrug Prescriptionsen_US
dc.subjectEducation, Medical, Undergraduateen_US
dc.subjectEducational Measurementen_US
dc.subjectEducational Statusen_US
dc.subjectEuropeen_US
dc.subjectHumansen_US
dc.subjectLearningen_US
dc.subjectPharmacology, Clinicalen_US
dc.subjectSurveys and Questionnairesen_US
dc.titleKey Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study.en_US
dc.typeArticleen_US
dc.rights.holder(c) 2017 The Authors.
dc.identifier.doi10.1002/cpt.962
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29205299en_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume104en_US
dcterms.dateAccepted2017-11-25
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution-NonCommercial License
Except where otherwise noted, this item's license is described as Creative Commons Attribution-NonCommercial License